Back to Library
Melanotan 1
FDA ApprovedFDA approved (as afamelanotide, brand name Scenesse) for erythropoietic protoporphyria.
Melanotan I
Description
An alpha-MSH analogue that stimulates melanogenesis for skin darkening. Provides photoprotection without UV exposure.
Dose:250 mcg
Frequency:2 days per week (8 weeks on/off cycle)
Administration Method: SQ
CategoryCognitive
Half-LifeApproximately 30-60 minutes (subcutaneous).
Overview
Melanotan 1 is a peptide that increases melanin production in the skin, enabling tanning with lower UV exposure.
Mechanism of Action
Melanotan 1 is an analog of alpha-melanocyte-stimulating hormone (α-MSH) that induces skin tanning by stimulating melanogenesis, leading to increased production and secretion of melanin and providing a protective mechanism against UV.
Benefits
- •Skin tanning
- •UV protection
- •Melanin production
- •Photoprotection
Dosing Notes
A common research protocol injects 0.15 mL once daily for 1-2 weeks, then 0.25 mL twice weekly for maintenance.
Reported Side Effects
- •facial flushing
- •nausea
- •new or darkened freckles